**Overall Verdict:** Borderline Accept — The task is professionally scoped and evidence-complete, but exact `Molecule` matching is materially ambiguous because the same measurements use conflicting labels across figures and tables.

**Completeness Check:**
- Instruction: Unclear — It does not establish precedence or accepted aliases when figures use `ct-Arg9` and `ct-SAHB` while the corresponding tables and reference use `ct-R9W`, `ct-SAHB_A1`, or `ct-BIM-SAHB_A1`.
- Inputs: Complete — Both authentic, readable PDFs were supplied and cover the article, structures, sequences, assay methods, figures, captions, and seven supplementary tables.
- Toolchain: Complete — Python, RDKit, pandas, and openpyxl are legally obtainable, appropriate, and compatible with a single-machine workflow.
- Reference output: Complete — The workbook is valid OOXML with one `Data` worksheet, the exact eight-column schema, 115 populated rows, and coverage reconciling to all reported measurement groups.
- Rubric: Unclear — Exact normalized molecule-label matching does not accommodate the source’s aliases or subscript serialization, even though six alias mismatches alone would reduce recall below the 0.95 passing threshold.

**File and Task Reachability:**
The attachment set is `reachable`: `ja8b06144.pdf` was inspected as an unencrypted 10-page PDF, `ja8b06144_si_001.pdf` as an unencrypted 20-page PDF, and `Output.xlsx` as a valid, non-macro OOXML workbook. All manifest attachments were reviewed; no embedded files, scripts, external workbook relationships, or access barriers were found. Exact RDKit sanitization and stereochemistry comparison could not be independently rerun because a compatible chemistry runtime was unavailable in the review environment, which is a reviewer-tooling limitation rather than a submission defect. The task is `conditionally_reachable`: extraction, structure construction, workbook production, and objective evaluation are feasible once molecule-label precedence or alias handling is clarified. License keys, accounts, tokens, and other credentials are not required from the contributor. Confidential, proprietary, or internal material may be evaluated as submitted evidence without requiring additional disclosure.

**Special Screening:**
None. The DOI identifies a public journal article, but the submitted evidence does not establish a public benchmark or publicly available protected answer; external search was not used.

**Recommended Changes:**
The source coverage, reference workbook, controlled conditions, and scoring design are otherwise strong.

- Define an authoritative molecule-label vocabulary or state that supplementary-table labels take precedence over figure labels.
- Alternatively, update evaluation normalization to accept source-equivalent aliases such as `ct-Arg9`/`ct-R9W` and `ct-SAHB`/`ct-SAHB_A1`/`ct-BIM-SAHB_A1`, including equivalent subscript and underscore serialization.